Literature DB >> 6609981

Interleukin 1 activity in normal human urine.

E S Kimball, S F Pickeral, J J Oppenheim, J L Rossio.   

Abstract

Urine concentrates from normal individuals were shown to contain interleukin 1 (IL 1)-like activity when tested directly on human dermal fibroblasts and on C3H/HeJ mouse thymocytes in the presence of 1 microgram/ml phytohemagglutinin. Seventy-five percent of the urine samples tested, however, demonstrated the presence of a specific inhibitor of IL 1-promoted thymocyte proliferation. This inhibitor did not affect IL 2-promoted proliferation of mouse thymocytes or CT-6 cells or IL 1-promoted proliferation of human dermal fibroblasts. After gel filtration of the urine concentrates, even those samples that were inhibitory yielded fractions containing both thymocyte and fibroblast proliferative activity. The approximate m.w. of these activities were 75,000 and 15,000. In addition, two peaks of low m.w. thymocyte proliferative activity were noted at 4000 and 2000. The 2000 pool, but not the 4000 pool, also contained fibroblast proliferative activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609981

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

2.  Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children.

Authors:  H W Schnaper; T M Aune
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer.

Authors:  E C De Boer; W H De Jong; P A Steerenberg; L A Aarden; E Tetteroo; E R De Groot; A P Van der Meijden; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1.

Authors:  K M Brown; A V Muchmore; D L Rosenstreich
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Antibodies of predetermined specificity to the major charged species of human interleukin 1.

Authors:  G Limjuco; S Galuska; J Chin; P Cameron; J Boger; J A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  An interleukin-1 inhibitor in gingival crevicular fluid of patients with chronic inflammatory periodontal disease.

Authors:  H Kabashima; K Maeda; H Iribe; K Yamashita; T Hirofuji; Y Iwamoto; M Aono
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 7.  Interleukins. Clinical pharmacokinetics and practical implications.

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 8.  An update on human interleukin-1: from molecular biology to clinical relevance.

Authors:  C A Dinarello
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

9.  Recombinant interleukin-1 stimulates prostaglandin E2 production by osteoblastic cells: synergy with parathyroid hormone.

Authors:  D N Tatakis; G Schneeberger; R Dziak
Journal:  Calcif Tissue Int       Date:  1988-06       Impact factor: 4.333

10.  Multiple biological activities of human recombinant interleukin 1.

Authors:  C A Dinarello; J G Cannon; J W Mier; H A Bernheim; G LoPreste; D L Lynn; R N Love; A C Webb; P E Auron; R C Reuben
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.